Notice Number: NOT-MH-08-002
Key Dates
Release Date: October 18, 2007
Issued by
National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov)
National Institute on Drug Abuse (NIDA) (http://www.nida.nih.gov)
Purpose
The purpose of this notice is to inform the research community that beginning with the May 2008 Council Round (i.e., October 5, 2007/ November 5, 2007 R01 receipt dates) NIMH and NIDA will offer New Investigators the option of submitting for consecutive review cycles a resubmission/amended R01 application to standing review committees.
As part of the National Institutes of Health continuing commitment to new investigators, a pilot effort (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-013.html) was begun in 2006 in the Center for Scientific Review (CSR) to allow new investigators to have the option of submitting a resubmission/amended R01 application for consecutive review cycles, saving four months. This pilot was extended broadly in subsequent cycles and has involved nearly 2000 new investigator R01 applications reviewed in the original 40 study sections in the Center for Scientific Review. Approximately 13% of the eligible new investigators have used the option of next cycle submission. Beginning with the September/October 2007 Study Section meetings the Center for Scientific Review is extending this to all new investigator R01 applications submitted for standard receipt dates (this does not include submissions for Funding Opportunity Announcements with special receipt dates) http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-083.html.
Joining this initiative are the newly participating NIMH Study Sections: Interventions Committee for Adult Mood and Anxiety Disorders (ITMA), Interventions Committee for Disorders Related to Schizophrenia, Late Life, or Personality (ITSP), Interventions Committee for Disorders Involving Children and Their Families (ITVC), Mental Health Services in Specialty Settings (SRSP), and Mental Health Services in Non-Specialty Settings (SRNS).
NIDA’s participating Study Sections include: Treatment Research Committee (NIDA-E), Health Services Research Committee (NIDA-F), and Medication Development Research Subcommittee (NIDA –L).
The NIMH and NIDA recurring study sections that review new investigator R01 applications will meet on a schedule to allow consecutive cycle resubmissions.
- Study Sections participating will schedule meetings so that new investigators receive their summary statements no later than March 1, July 1, or November 1.
- The Summary Statements for qualifying applications will have an explicit note indicating eligibility for next cycle submission.
- Resubmission applications for consideration at the next cycle must be submitted by March 20, July 20, or November 20.
- New Investigators who do not choose the next cycle option will use the standard resubmission dates for subsequent cycle submission (March 5, July 5, or November 5).
NIH Definition of a New Investigator
See http://grants1.nih.gov/grants/new_investigators/resources.htm#definition for current definition.When Multiple Principal Investigators are proposed, all PIs must meet the definition of new investigator to qualify for shortened review cycle consideration (http://grants.nih.gov/grants/multi_pi/overview.htm).
Inquiries
NIMH:
Jean G. Noronha, Ph.D.
Referral Liaison, Division of Extramural Activities
National Institute of Mental Health
6001 Executive Blvd, Room 6147, MSC 9609
Bethesda, MD 20892-9609
Rockville, MD 20852 (for express/courier service)
Telephone: 301-443-3367
FAX: 301-443-4720
Email: [email protected]
NIDA:
Teresa Levitin, Ph.D.
Director, Office of Extramural Affairs
National Institute on Drug Abuse/NIH/DHHS
6101 Executive Boulevard, Suite 220, MSC 8401
Bethesda, MD 20892-8401
Rockville, MD 20852 (for express/courier service)
Telephone: (301) 443-2755
FAX: (301) 443-0538
Email: [email protected]
and Human Services (HHS)
